Still Not Believing

Over the past week the majority of our market health indicators improved. None of them improved enough to change our core portfolio allocations. Unfortunately, the indicators still aren’t believers in this rally. They continue to show underlying weakness. Happy New Year everyone!

Hugh Hendry And The “Blue Pill”

Distorted Markets We have always liked Eclectica fund manager Hugh Hendry for his sound views and outspoken manner. Below is a somewhat dated video compilation showing several moments in which he stunned his opponents in television debates by voicing uncomfortable and politically incorrect truths. Included in the video is a defense of speculators, entrepreneurs and…

E

Shares of NephroGenex (NRX) soared as high as 200% on Wednesday after the company announced an excellent safety profile for its drug Pyridorin which treats diabetic nephropathy — diabetic kidney disease. Diabetic nephropathy is a chronic disease of the kidney caused by diabetes. There are around 19 million people in the U.S. diagnosed with diabetes….